Whereas moderate drinking may have health benefits, excessive alcohol consumption causes many important acute and chronic diseases and is the third leading contributor to preventable death in the United States. Twin studies suggest that alcohol-consumption patterns are heritable (50%); however, multiple genetic variants of modest effect size are likely to contribute to this heritable variation. Genome-wide association studies provide a tool for discovering genetic loci that contribute to variations in alcohol consumption. Opportunities exist to identify susceptibility loci with modest effect by meta-analyzing together multiple studies. However, existing studies assessed many different aspects of alcohol use, such as typical compared with heavy drinking, and these different assessments can be difficult to reconcile. In addition, many studies lack the ability to distinguish between lifetime and recent abstention or to assess the pattern of drinking during the week, and a variety of such concerns surround the appropriateness of developing a common summary measure of alcohol intake. Combining such measures of alcohol intake can cause heterogeneity and exposure misclassification, cause a reduction in power, and affect the magnitude of genetic association signals. In this review, we discuss the challenges associated with harmonizing alcohol-consumption data from studies with widely different assessment instruments, with a particular focus on large-scale genetic studies.
INTRODUCTION
Excessive alcohol consumption is among the leading contributors to morbidity and mortality worldwide (1) . According to the Centers for Disease Control and Prevention, an average of 79,000 deaths/y in the United States between 2001 and 2005 were attributable to the acute and chronic effects of alcohol. Whereas moderate alcohol consumption (2 drinks/d for men and 1 drink/d for women) may have some health benefits (2, 3) and disadvantages (4) , heavy drinkers are at increased risk of alcohol-related health conditions (5, 6 ) and alcoholism-a serious and fairly common psychiatric disorder.
Alcohol consumption, including excessive drinking, is influenced by heritable factors (7) (8) (9) (10) . Approximately 50% of the variance in alcohol consumption is attributable to additive genetic factors (11, 12) . A recent genetic study of an Asian population produced highly significant results (P , 10 258 ) for SNPs 6 neighboring the ALDH gene, ALDH2 (13) , which is involved in alcohol metabolism. Despite this success, the initial GWAS of alcohol consumption (14) and alcohol dependence (15) (16) (17) in European-American samples identified few variants approaching genome-wide significance (P , 5 · 10
28
). It is likely that multiple genetic variants of modest effect contribute to the amount of alcohol consumed, particularly in non-Asian samples, and we anticipate that extremely large sample sizes will be needed to have the statistical power to detect them. Such large sample sizes must be obtained by pooling together data from multiple studies via meta-analysis-an approach that has yielded considerable success for identifying genetic variants that contribute to heaviness of cigarette smoking (18) (19) (20) (21) (22) and many other phenotypes.
Why are GWAS of alcohol consumption so challenging? One of the major challenges is phenotype heterogeneity due to differences in the ways that studies assess alcohol intake. Individual studies vary markedly in their objectives for collecting alcoholrelated information and therefore differ in their means of measuring consumption and in the period of interest. For instance, a study of alcoholism may collect data on a participant's lifetime history of heavy drinking, whereas a study of breast cancer may query respondents on light to moderate levels of alcohol intake to model its effects on breast cancer (23, 24) . This measurement heterogeneity has significant implications for genetic studies. In this review, we discuss the genetic underpinnings of alcohol consumption, potential sources of measurement heterogeneity, and the extent to which differences between studies may affect genetic analyses.
IS ALCOHOL CONSUMPTION HERITABLE?
Alcohol use can be conceptualized as a series of different stages starting from initiation of use, transitioning to regular use, and potentially leading to excessive use and alcoholism (25) , as shown in Figure 1 . Whereas most aspects of alcohol use are heritable (ie, influenced, to some degree, by genetic factors) (26), drinking initiation (or conversely lifetime abstention) tends to be the least influenced by genetic factors (27) (28) (29) and rather appears to be determined primarily by familial environment (30, 31) . For example, religion and culture have strong influences on whether and when a person starts to drink. However, once alcohol use is initiated, many domains of alcohol use-including current use, pattern of use, and heaviest use-are influenced by underlying genetic variation and are heritable (h 2 ' 50%) (8, (32) (33) (34) . There is substantial correlation between each of these domains and, similarly, there is estimated to be overlap of genetic factors, up to 90%, across them (8, 9, 33, 34) . Furthermore, these heritable characteristics of alcohol intake overlap with genetic vulnerability to alcoholism (genetic correlations 0.9) (8, 32) . Environment, of course, continues to be an important contributor to all these domains, and the context of these environmental influences vary across the stages (Figure 1 ).
Understanding the different stages of alcohol use and abuse and the biases that affect their measurement can aid us in improving genetic studies. For instance, given the stages of alcohol use and the proposed common and specific genetic and environmental influences that contribute to each stage, we anticipate that the likelihood of identifying genetic influences that contribute to alcohol consumption will decrease if lifetime alcohol abstainers are combined with light drinkers or former drinkers when measures of alcohol consumption are constructed (eg, a never drinker was coded as having drunk 0 drinks/wk) (35) , because nondrinkers at a particular time point include both those who have never drank, those who drank a lot in the past but have quit, and those who drink alcohol occasionally but only drink a small amount.
WHAT IS KNOWN ABOUT GENETIC VARIATION IN ALCOHOL CONSUMPTION?
Genes in the ADH and ALDH complex that regulate alcohol metabolism (36) are among the most established genetic contributors to all aspects of drinking. The metabolism of alcohol involves conversion of alcohol to acetaldehyde, by ADH and then acetaldehyde to acetate, by ALDH. Variants in the genes encoding ADH and ALDH, some of which are more common in Asians (37) , are known to regulate alcohol metabolism to varying degrees. Defects in this pathway can lead to high concentrations of the intermediate metabolite acetaldehyde, which causes flushing (facial reddening) accompanied by nausea, dizziness, and other unpleasant physiologic symptoms); thus, individuals who experience this reaction are considerably less likely to continue to drink (38) . Although there are several intriguing polymorphisms in the ADH and ALDH Center (DK46200; QS), U01HG004399 (FH), NIH R01 HL71981 and K99HL098459 (QS), American Heart Association Scientist Development Award (LQ), and the Canadian Institutes of Health Research (MCC). Dental Caries: Study: "Dental Caries: Whole Genome Association and Gene Environment Studies" 1-U01-DE018903, PI Marazita. (Included in the alcohol cross-study were the Levy (IOWA) and Marazita (PITT) study populations so the acknowledgements below reflect only those studies.) Funding support for the GWAS was provided by the National Institutes of Dental and Craniofacial Research (NIDCR) as part of the trans-NIH GEI (U01-DE018903). Data and samples were provided by the Center for Oral Health Research in Appalachia (a collaboration of the University of Pittsburgh and West Virginia University funded by NIDCR R01-DE 014899) and the Iowa Fluoride Study and the Iowa Bone Development Study, funded by NIDCR R01-DE09551 and R01-DE12101, respectively. Genotyping was done by the Johns Hopkins University Center for Inherited Disease Research (CIDR), which is fully funded through a federal contract from the NIH to The Johns Hopkins University (contract number HHSN268200782096C). Funds for this project's genotyping were provided by the NIDCR through CIDR's NIH contract. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GENEVA Coordinating Center (U01gene families, 2 coding SNPs are of note. In the ADH1B gene, one allele of rs1229984 leads to accelerated oxidation of alcohol to acetaldehyde; in ALDH2, one allele of rs671 leads to nearly no activity of the mitochondrial ALDH (36) . These polymorphisms are robustly correlated with alcohol consumption and dependence (39) (40) (41) . However, the allele frequencies of the most protective variants are very low in European populations, which leaves most of the heritability in these populations to be explained by other genes. Despite this, a recent study found strong support for the protective effect of rs1229984 on alcohol dependence in Europeans and African Americans (42) .
Many other genes that may be associated with the personality characteristics of drinkers (eg, impulsivity and disinhibition) and loss of control and other neurobiological consequences of drinking (eg, alcohol-induced blackouts and tolerance) are likely to also be involved (12, 26) . Because these genetic variants are likely to individually exert only modest effects on alcohol consumption, it is a considerable challenge to identify them. Accumulating very large samples that draw phenotypic and genomic data from multiple sources provides one such exciting way to address this challenge.
THE ADVANTAGE OF GWAS META-ANALYSIS
How a meta-analysis of GWAS proceeds is outlined in Figure 2 . In addition to harmonizing phenotypes, as is typically performed in all meta-analyses, genotypes from various platforms also need to be harmonized, via imputation, to a common scale (eg, HapMap, 1000 Genomes). Three large-scale GWAS meta-analyses of cigarette smoking have now definitively validated the role of a missense mutation (rs16969968 or its proxy rs1051730) (43) in the cluster of CHRNA5-CHRNA3-CHRNB4 genes on chromosome 15 (19, 21, 22) . However, to achieve levels of appropriate statistical significance that overcome potential type I error from multiple comparisons, samples exceeding 40,000 (with the largest sample exceeding 140,000) were necessary. The success with GWAS of smoking behavior offers the hope that alcohol consumption and alcohol dependence can be similarly studied in large population samples. Recently, such a meta-analysis of alcohol consumption identified an SNP in the AUTS2 (autism susceptibility) gene to be associated with alcohol consumption (daily ethanol intake in g/kg body mass; P = 4.1 · 10 29 ) (44). They also reported significant expression differences in this gene across high compared with low alcohol-preferring mice. More than 42,000 subjects were included in this meta-analysis, and the overall effect size was modest. Although this is an exciting development for genetic studies of alcohol consumption, unlike rs16969968 for smoking, the role of AUTS2 in alcohol consumption remains to be validated. Of course, additional loci are most likely involved in the genetics of both alcohol and smoking.
Meta-analyses, whether epidemiologic or genetic, implicitly require a minimum level of comparability across studies ( Figure  2 ). Even though a meta-analysis aggregates across results from within-study analyses, across-study heterogeneity influences the comparability of effect sizes (eg, regression coefficients and ORs) when there is heterogeneity in the measured endpoint. The effect of measurement heterogeneity on gene finding is affected by the extent to which common loci underlie the genetic contribution to the distinct aspects of alcohol use (eg, drinking frequency, quantity, and alcohol dependence) being meta-analyzed. In the following sections, we discuss key contributors to heterogeneity in the measurement of alcohol consumption and describe their potential effect on the GWAS meta-analyses of these phenotypes.
MEASURING ALCOHOL CONSUMPTION
Measures of alcohol consumption typically include drinking quantity (eg, how many drinks in a given reference period, such as drinks/wk or drinks/d) and frequency (eg, how often one drinks in a given reference period, such as drinking days/wk). These measures can be assessed during various reference periods: in the past 30 d, in the past 12 mo, over a lifetime, during a period of "typical" or "usual" alcohol consumption, or during a period of heaviest use. Although assessed by fewer studies, differences between drinking a certain amount of alcohol over the week or at one sitting are also important. For example, the maximum number of drinks consumed within a single 24-h period is also heritable and is highly correlated with a person's vulnerability to excessive alcohol consumption (8, 32, 45) .
WHY MEASUREMENT HETEROGENEITY OCCURS
Alcohol consumption is an aspect of normative diet, a risk factor for a variety of health-related outcomes, and an addictive substance. Thus, depending on the goals of a study, measures of alcohol consumption can be collected by using food-frequency questionnaires, from medical charts, via self-report in case-control studies of health-related outcomes, and from interviews in studies for addiction and other psychiatric disorders. To illustrate this remarkable variation in the assessment of alcohol consumption, representative alcohol-consumption measures from individual studies of the GENEVA Consortium are shown in Table 1 (46, 47) .
Within each of these realms of research, significant effort has been made to harmonize measures of alcohol consumption. For example, disparate measures of alcohol can be converted into exposure categories (48) , and categories of safe compared with unsafe consumption (49) have been developed for studies of allcause mortality. Similar efforts have been directed at developing harmonized alcohol-consumption measures for studies of cancer (50) . Alcohol intake data collected by using various foodfrequency questionnaires tend to correlate highly (51, 52) . However, reducing measurement heterogeneity within a set of studies with a common theme (eg, alcohol and cancer) does not ensure that these alcohol measures can themselves be combined with alcohol use assessed in studies focused on other endpoints, ie, if one is interested in identifying the genetic underpinnings of alcohol consumption, variations in the alcohol measures presented in Table 1 may still pose a challenge.
SOURCES OF MEASUREMENT HETEROGENEITY
The challenges associated with measurement heterogeneity for alcohol consumption, particularly in the context of genomic studies, are listed in Table 2 . Some of these challenges are not unique to alcohol consumption (eg, recall bias), and others are fairly straightforward (eg, conversion of ethanol grams in a standard drink across different countries). However, some key concerns that are unique to alcohol consumption (eg, episodic nature of drinking and recent abstention) can produce spurious results because of the misclassification of subjects. Whereas we emphasize those issues that bear major concerns for genetic analyses, readers interested in issues related to the general measurement of alcohol consumption are invited to read a review of this topic by Dawson (53) .
Interpretation of abstention
Lifetime abstainers are uncommon in several populations. They are worth excluding from genetic studies of alcohol use and alcohol dependence, because alcohol initiation is more strongly affected by religious and cultural norms. Individuals with a family history of alcoholism may also abstain from alcohol to avoid developing the disorder, because these individuals are at higher genetic risk. Lifetime drinkers may also report recent abstention due to a host of environmental factors (eg, life events and pregnancy) (54), due to health factors (eg, gastrointestinal disease) (55), or due to enrollment in a treatment program for alcohol dependence (eg, Alcoholics Anonymous) (56) . Thus, an individual with alcohol dependence may have susceptibility loci for alcohol use, yet be inadvertently misclassified as a light or nondrinker because of limitations in the design of the study in which they participated. Studies that do not assess lifetime use are particularly affected by this issue, because they cannot distinguish between lifetime and recent abstainers.
The episodic nature of alcohol consumption
Drinking, unlike smoking, is often episodic and can vary considerably across periods of recent (past 12 mo, past 30 d, or FIGURE 2. Stages of meta-analysis of genetic data-an illustration. ADH, alcohol dehydrogenase; ALDH, aldehyde dehydrogenase; GABRA2, g-aminobutyric acid receptor subunit A2; GWAS, genome-wide association studies.
TABLE 1
Illustration of across-study variation in data collected on alcohol consumption in the Gene, Environment Association (GENEVA) Consortium 
Quantity and frequency across reference periods
Uniform measures of alcohol consumption have not been universally adopted. Attempts to harmonize the varying reference periods (drinks/d, drinks/wk, or drinks/mo) used in different studies without a measure of drinking frequency (eg, How many days a week do you drink?) can lead to biases, particularly because of the episodic nature of alcohol consumption. For instance, assume that a study assesses drinks/d, and the respondent reports drinking 2 drinks/d. We are interested in a measure of drinks/wk, but we do not know whether the individual drinks only on weekends. Do we compute 14 drinks/wk (2 drinks/d · 7 d), which is a significant inflation over the accurate 4-6 drinks/wk, or do we simply use drinks/d as the measure from that study?
Differences in cultural norms across studies
Alcohol intake varies substantially by population and is affected by sex, geographic region, and cultural practices. For example, intake among US Seventh-Day Adventists (58) varies substantially from that among indigenous Canadian and Alaskan native populations, such as Inuit (59) (60) (61) . The substantial range in alcohol intake across populations is another challenge when pooling data. For example, although drinking 1 or 2 glasses of wine per day with dinner may be very common in some populations, it would be considered very extreme in other populations. Thus, susceptibility loci for alcohol intake are affected by the broader environmental context. These complicated interactions are challenging to account for within the meta-analytic framework.
Beverage forms
Considerable sociocultural and individual-specific variation in the choice of alcoholic beverage consumed also exist, and it is well recognized that reported alcohol consumption is higher when participants are asked about individual beverage types (beer, wine, and liquor) separately rather than about "alcoholic beverages" as a group (62, 63) . On the other hand, for many alcohol-associated outcomes, such as cancer, it is thought that ethanol is the important factor, regardless of its source. Should measures drawn from specific alcoholic beverages be combined with data drawn from single item assessments of "drinks"? One possible mechanism for harmonizing these varying assessments is via conversion to ethanol grams, which as discussed below, requires many assumptions.
Standard drinks and conversion to ethanol grams
Although cigarettes can vary in their nicotine content, most smokers consume cigarettes in a pack of standard size, thus establishing a "metric" for their report. Alcohol, in contrast, is consumed as a variety of beverages with varying ethanol contents, forms (eg, mixed drinks and coolers), and quantities (eg, can of beer and beer on tap) that render an estimate of the number of standard drinks (ie, amount of ethanol) (64) difficult to quantify. Drink size and ethanol content may also vary by country. The ability to reconcile these differences by conversion relies heavily on the participant's understanding of the definition of a "standard drink." For instance, a drinker may report drinking a glass of wine every day but drinks the wine in a large "balloon" Because of the episodic nature of drinking, an individual reporting consuming 3 drinks/d, on average, cannot be assumed to be drinking 21 drinks/wk (ie, assumption that drinking is constant every day of the week).
Cultural norms
Drinking regularly may be normative in some cultures but unacceptable in others. Assessing different beverage forms An individual reports greater alcohol intakes when responding to questions on beer, wine, and spirits compared with a single question on "alcoholic drinks." Conversion to grams of ethanol requires participant understanding of a "standard" drink An individual drinks red wine at home, and unless prompted with visual cue, it is unclear whether their pour of wine reflects a standard pour. Recall bias and bias attributable to other respondent characteristics (eg, underreporting by overweight/obese individuals)
An overweight individual reports fewer drinks because of weight concerns.
glass, which can contain the equivalent of 2 to 3 standard drinks; hence, alcohol consumption and ethanol grams are underestimated. Picture cards or verbal/visual references of standard drinks by beverage type (eg, beer compared with malted beer; table wine compared with fortified wine) might be used to orient respondents to the meaning of a standard drink. However, this may not always be feasible within the context of a food-frequency questionnaire.
Recall and other respondent biases
Finally, although not unique to alcohol, much like most selfreported measures, general elements of recall bias may also contribute to measurement inaccuracy. Recall can be biased by characteristics correlated with drinking. For instance, underweight individuals have been found to overestimate and overweight/obese individuals tend to underreport certain aspects of the diet (eg, fats and simple carbohydrates) (65, 66) ; this may apply to alcohol consumption as well. Although statistical approaches have been developed to address these issues, these efforts, even if successful, can have an effect on study power.
THE FUTURE OF GWAS META-ANALYSES OF ALCOHOL CONSUMPTION
Understanding the etiology of a behavior that is, at once, both a feature of normal diet and a serious and common psychiatric disorder, and a substantial cause of chronic disease, is a critical public health issue. In this regard, it is reassuring that GWAS meta-analyses have proven to be successful at addressing for other complex phenotypes, including behavioral measures (67, 68) . Furthermore, simulation studies suggest that, even with exposure misclassification, very large studies can succeed at identifying susceptibility loci (69) . Importantly, if even a subset of genetic influences is common across each alcohol metric, then a meta-analysis should be able to identify genes contributing to this shared genetic propensity, given a large enough data set. In contrast, those genetic influences that are specific to particular aspects of alcohol consumption will require careful harmonization of intake measures.
For future studies that plan on including alcohol-consumption measures, several resources are available to guide investigators with data collection, and they are listed in Table 3 . For instance, the PhenX Toolkit (70) offers questions on a variety of alcoholconsumption measures, including definitions of standard drinks as well as visual references of sizes of standard beverage servings. PhenX also offers items to assess lifetime use, age at first use, and symptoms of alcohol dependence for studies interested in a more detailed assessment of maladaptive drinking. The National Institute on Alcohol Abuse and Alcoholism offers several assessments (eg, AUDIT) that can be used to screen for and measure quantity, frequency, and liability to abuse and dependence.
We recognize that investigators collect measures of alcohol consumption that maximally inform their outcome of interest and that efforts to minimize respondent burden may limit the extent to which common assessments are used across studies. It is hoped that the concerns raised in this review will encourage investigators to consider the inclusion of a well-validated measure that indexes heritable variation in the tendency to drink alcohol in their study. We recommend the inclusion of maximum drinks consumed in a single 24-h period. This single low-burden item was heritable (h 2 = 50%) (8, 32) , associated with ADH variants (40), was found to correlate strongly with liability to alcohol consumption and alcoholism, and may also indicate alcohol tolerance. Even in cultures in which maximum drinks may reflect a "rite of passage," such as drinking on one's 21st birthday in the United States, symptoms of alcohol dependence have been found to correlate strongly even with this isolated instance of heavy drinking (71) . Undoubtedly, cultural, societal, and other environmental factors influence this measure and its correspondence with lifetime alcoholism risk. Not all individuals with a lifetime high number of maximum drinks consumed in a single 24-h period may subsequently develop alcoholism. In detailed assessments, indexes of quantity and frequency of drinking augment information from maximum drinks.
Existing and ongoing studies should recognize the context of genomic findings that arise from the combination of such heterogeneous sources and model random effects or calculate other metrics of heterogeneity (see reference 72 for a review of these metrics) when conducting genetic analyses. Even though there has been discussion surrounding the lower power in smaller studies to detect heterogeneity (73) , this is necessary for alcohol intake. In fact, evidence for between-study heterogeneity can ultimately lead to new discoveries (eg, genes relevant only in individuals exposed to certain environments) (74) . There is often a trade-off between heterogeneity and the sample size necessary to detect the effects of genes (69); thus, augmenting the sample size can help. From a technical perspective, investigators may wish to consider statistical methods developed for the analysis of covariates as outcomes in genomic Discussion of measurement-related issues for alcohol (53) studies, as is typically the case for alcohol consumption (75) . Biases in such studies are most pronounced when the primary and secondary traits are correlated with one another or if the marker jointly influences both traits. In these instances, methods such as inverseprobability-of-sampling weighted regression may be more appropriate. Many such meta-analytic efforts are currently ongoing and are accounting for these technical caveats and amassing tens of thousands of subjects, heralding a brand new era of discovery for the genetics of alcohol consumption. We invite investigators with relevant alcohol-related information and GWAS data to join and participate in these ongoing efforts.
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